Oncimmune inks distribution deal for lung cancer test in Portugal
5th Apr 2019 15:10
(Sharecast News) - Personalised immunodiagnostics developer Oncimmune Holdings has signed an exclusive agreement for the distribution of its 'EarlyCDT-Lung' test kit in Portugal with Sabartech, its existing distributor in Spain, it announced on Friday.
Read moreOncimmune strengthens scientific board with addition of Parag Mallick
2nd Apr 2019 10:50
(Sharecast News) - Immunodiagnostics company Oncimmune Holdings announced the appointment of Dr Parag Mallick - an associate professor of radiology at Stanford University - to its scientific board on Tuesday.
Read moreOncimmune acquires Protagen Diagnostics in £4.11m deal
19th Mar 2019 09:10
(Sharecast News) - Oncimmune Holdings has acquired Protagen Diagnostics for a total consideration of up to £4.11m, it announced on Tuesday, to be paid by the allotment of up to 2,635,910 Oncimmune ordinary shares at 156p each 0 a premium of 71% to the closing mid-market price on 18 March.
Read moreOncimmune Holdings' loss deepens on spiralling costs
13th Feb 2019 09:20
(Sharecast News) - Oncimmune Holdings reported a widened interim loss on Wednesday as increases to research & development costs and administrative costs outweighed a rise in revenue.
Read moreOncimmune buoyed by US distribution deal for blood tests
20th Dec 2018 16:27
(Sharecast News) - Oncimmune Holdings made gains on Thursday after it entered an agreement with America's Choice Provider Network to expand access to its EarlyCDT-Lung and EarlyCDT-Liver blood tests.
Read moreOncimmune signs sales deals in multiple countries for 'EarlyCDT-Lung' test
28th Nov 2018 11:57
(Sharecast News) - Immunodiagnostics developer Oncimmune Holdings has signed exclusive agreements for the distribution of its 'EarlyCDT-Lung' test in Germany with hrmed.tech, in France with Eurobio Scientific, and in Italy with BSN, it announced on Wednesday.
Read moreOncimmune inks multiple new distribution agreements
1st Oct 2018 12:47
(Sharecast News) - Oncimmune revealed on Monday that it had signed multiple new distribution agreements for its EarlyCDT-Lung test as part of an early morning trading update.
Read moreRevenue shrinks and costs rise at Oncimmune
7th Nov 2016 15:17
(ShareCast News) - Early cancer detection company Oncimmune Holdings announced its full year results for the year to 31 May on Monday, including £12.2m raised by the issue of equity in the year. The firm also said £4.2m of convertible loan notes were converted. Revenues for the year were down signi
Read moreOncimmune secures CE mark for EarlyCDT-Lung
15th Jul 2016 16:17
(ShareCast News) - Early cancer detection technology company Oncimmune Holdings announced on Friday that it has obtained the CE mark for the reagents used in its EarlyCDT-Lung product - an autoantibody blood test that can detect cancer up to four years earlier than other methods. The AIM-traded firm
Read moreOncimmunce Holdings CFO Robert Page dies
6th Jun 2016 16:44
(ShareCast News) - Robert Page, director and CFO of Oncimmune Holdings, has died unexpectedly from natural causes. Oncimmune Holdings, an early cancer detection and technology company, said Page died on Friday morning. Page became CFO in 2005 after holding a series of finance roles at telecommunica
Read more